Argo Biopharma Selects Banks for Hong Kong IPO, Expected to Generate Hundreds of Millions of USD
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 06 2025
0mins
Source: aastocks
IPO Plans: Argo Biopharma, a Chinese biotechnology firm, is preparing for an IPO in Hong Kong, aiming to raise hundreds of millions of USD.
Bank Partnerships: The company has engaged Bank of America, CICC, Jefferies, and JPMorgan to manage the IPO and has submitted its listing application confidentially.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
